The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic biochemical pathways without original human clinical data.
PubMed 30050410 · doi:10.3389/fncel.2018.00169
What was done
This narrative review synthesized biochemical and mechanistic literature regarding neuronal acetyl-CoA synthesis, its compartmental distribution between mitochondria and cytoplasm, and its dysregulation in neurodegenerative brain disorders.
What was found
Acetyl-CoA concentrations in neuronal mitochondrial and cytoplasmic compartments are reported in the range of 10 and 7 μmol/L, respectively. These concentrations are 2 to 20 times lower than the acetyl-CoA Km values for carnitine acetyltransferase, acetyl-CoA carboxylase, aspartate acetyltransferase, choline acetyltransferase, sphingosine kinase 1 acetyltransferase, acetyl-CoA hydrolase, and acetyl-CoA acetyltransferase. Consequently, shifts in acetyl-CoA levels directly modulate fluxes through acetylation reactions affecting acetylcholine synthesis, protein acetylation, and gene expression, while pyruvate dehydrogenase inhibition, intracellular zinc excess, and amyloid-β 1-42 accumulation exacerbate energy and structural collapse.
Why it matters
Because physiological acetyl-CoA concentrations fall below enzyme saturation limits, acetyl-CoA availability acts as a direct regulatory switch for brain metabolic and acetylation pathways involved in neurodegeneration.
Limits
The abstract describes a narrative review without systematic search criteria or original clinical trial data. No clinical sample size, patient demographics, or quantitative clinical outcomes are reported.
Cited by
- supports Coenzyme A is biochemically required for the synthesis of acetylcholine, cortisol, and melatonin.